Page last updated: 2024-09-05
avasimibe and gw9662
avasimibe has been researched along with gw9662 in 1 studies
Compound Research Comparison
| Studies (avasimibe) | Trials (avasimibe) | Recent Studies (post-2010) (avasimibe) | Studies (gw9662) | Trials (gw9662) | Recent Studies (post-2010) (gw9662) |
|---|---|---|---|---|---|
| 77 | 6 | 30 | 617 | 0 | 406 |
Protein Interaction Comparison
| Protein | Taxonomy | avasimibe (IC50) | gw9662 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.3 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.086 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Benéteau, N; Chapuis, V; Colpaert, FC; Dupont-Passelaigue, E; Junquéro, D; Lestienne, F; Patoiseau, JF; Rival, Y; Taillandier, T | 1 |
Other Studies
1 other study(ies) available for avasimibe and gw9662
| Article | Year |
|---|---|
Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
Topics: Acetamides; Acetates; Anilides; Cardiovascular Agents; Cell Line; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mevalonic Acid; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tetradecanoylphorbol Acetate; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors | 2004 |